Shareholders Equity: The sum of preferred and common equity items.
ANI Pharmaceuticals, Inc. (ANIP) had Shareholders Equity of $540.72M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$883.37M |
|
$77.18M |
|
$341.31M |
|
$542.06M |
|
$772.27M |
|
$111.09M |
|
$-15.30M |
|
$95.79M |
|
$95.79M |
|
$78.34M |
|
$78.34M |
|
$78.34M |
|
$78.34M |
|
$111.09M |
|
$202.51M |
|
20.05M |
|
21.23M |
|
$3.50 |
|
$3.32 |
|
| Balance Sheet Financials | |
$753.12M |
|
$62.48M |
|
$687.26M |
|
$1.44B |
|
$278.11M |
|
$599.77M |
|
$621.54M |
|
$899.65M |
|
$540.72M |
|
$-1.28M |
|
|
Shareholders Equity |
$540.72M |
22.50M |
|
| Cash Flow Statement Financials | |
$185.22M |
|
$-34.32M |
|
$-9.94M |
|
$144.89M |
|
$285.62M |
|
$140.73M |
|
$37.93M |
|
-- |
|
$-1.16M |
|
| Fundamental Metrics & Ratios | |
2.71 |
|
-- |
|
-- |
|
0.53 |
|
1.14 |
|
61.36% |
|
12.58% |
|
12.58% |
|
22.92% |
|
10.84% |
|
8.74% |
|
$171.39M |
|
-- |
|
-- |
|
-- |
|
0.61 |
|
2.39 |
|
3.14 |
|
116.14 |
|
14.49% |
|
-6110.32% |
|
5.44% |
|
6.87% |
|
$24.03 |
|
$8.07 |
|
$8.73 |
|